ArticleJournal of Cancer2020

Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma

Shujuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.